🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
7.00
-0.46 (-6.17%)
Nov 19, 2026, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
27.7634.6922.2630.5619.789.94
Short-Term Investments
74.1571.8244.5557.04640.96
Cash & Short-Term Investments
101.91106.5166.8187.683.7910.9
Cash Growth
6.35%59.42%-23.73%4.55%668.95%-69.56%
Receivables
0.060.10.090.10.10.12
Inventory
0.220.310.170.150.280.07
Prepaid Expenses
0.990.992.091.270.530.23
Total Current Assets
103.17107.9169.1789.1184.6911.32
Property, Plant & Equipment
3.293.213.492.833.681.12
Long-Term Investments
-2.52.52.52.50.4
Long-Term Deferred Charges
----40.1
Other Long-Term Assets
1.281.241.020.770.710.59
Total Assets
107.74114.8676.1795.2195.5713.53

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.036.15.132.93.972.03
Accrued Expenses
8.379.896.085.155.381.89
Current Portion of Long-Term Debt
-----2
Current Portion of Leases
0.830.750.550.650.7-
Current Unearned Revenue
--4.442.516.445.54
Other Current Liabilities
----2.090.78
Total Current Liabilities
14.2316.7416.2111.2118.5712.24
Long-Term Debt
72.4130.7514.29-9.493.67
Long-Term Leases
0.30.941.691.041.68-
Long-Term Unearned Revenue
--10.9914.9213.116.86
Other Long-Term Liabilities
2.053.060.04-0.20.54
Total Liabilities
88.9951.4843.2227.1743.0433.31

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.01000-
Additional Paid-In Capital
433.7416.08342.78316.9252.2794.89
Retained Earnings
-425.78-362.58-309.88-248.85-199.73-166.13
Comprehensive Income & Other
-0.150.060.05-0.01-0.01-
Total Common Equity
7.7853.5732.9668.0452.53-71.23
Shareholders' Equity
18.7563.3832.9668.0452.53-19.78
Total Liabilities & Equity
107.74114.8676.1795.2195.5713.53

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
73.5432.4416.531.6911.875.67
Net Cash (Debt)
28.3674.0850.2885.9171.925.22
Net Cash Growth
-55.42%47.32%-41.47%19.46%1276.89%-80.17%
Net Cash Per Share
0.451.551.372.594.802.47
Filing Date Shares Outstanding
78.758.5238.3135.782.522.19
Total Common Shares Outstanding
61.4557.0338.1935.782.522.19
Working Capital
88.9491.1852.9677.9166.12-0.92
Book Value Per Share
0.130.940.861.9020.83-32.60
Tangible Book Value
7.7853.5732.9668.0452.53-71.23
Tangible Book Value Per Share
0.130.940.861.9020.83-32.60
Machinery
4.033.192.532.122.081.51
Construction In Progress
-----0.02
Leasehold Improvements
0.170.160.160.20.190.18
SEC Filings: 10-K · 10-Q